Applying PAT to Vaccine Manufacturing

In this audio interview at IFPAC, Mathieu Streefland of the Netherlands Vaccine Institute discusses the progress his group is making toward applying PAT to the unwieldy world of vaccine manufacturing.
Feb. 28, 2006

Click the Download Now button below to access this .mp3 file.

About the Author

Paul Thomas

Managing Editor

Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates

Related

Eli Lilly’s new Concord, North Carolina site was built with NASCAR-like speed
Celltrion to buy US biologics manufacturing plant as part of tariff response strategy
OnTrak Wireless: Total Bearing Health Solution
Sponsored
OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified
Sponsored